Il Minn, Ph.D.

 Featured Publications

Follicle-Stimulating Hormone Receptor Expression and Its Potential Application for Theranostics in Subtypes of Ovarian Tumors: A Systematic Review.

Bakker ME, Brink GJ, Poot AJ, Braat AJAT, Jonges GN, Zweemer RP, Cancers (Basel) 2024 Mar 16 6

Imaging Brain Injury in Former National Football League Players.

Rubin LH, Du Y, Sweeney SE, O'Toole R, Thomas CL, Zandi AG, Shinehouse LK, Brosnan MK, Nam H, Burke ME, Bureau SC, Kilgore JJ, Yoon M, Soule AR, Lesniak WG, Minn I, Rowe SP, Holt DP, Hall AW, Mathews WB, Smith GS, Nowinski CJ, Kassiou M, Dannals RF, Pomper MG, Coughlin JM, JAMA Netw Open 2023 Oct 6 10 e2340580

Preclinical Evaluation of a New Series of Albumin-Binding ¹⁷⁷Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics.

Boinapally S, Alati S, Jiang Z, Yan Y, Lisok A, Singh R, Lofland G, Minn I, Hobbs RF, Pomper MG, Banerjee SR, Molecules 2023 Aug 28 16

First-in-human imaging using [¹¹C]MDTC: a radiotracer targeting the cannabinoid receptor type 2.

Du Y, Coughlin JM, Brosnan MK, Chen A, Shinehouse LK, Abdallah R, Lodge MA, Mathews WB, Liu C, Wu Y, Minn I, Finley P, Hall AW, Lesniak WG, Dannals RF, Horti AG, Pomper MG, Eur J Nucl Med Mol Imaging 2023 Jul 50 8 2386-2393

Hetero-bivalent agents targeting FAP and PSMA.

Boinapally S, Lisok A, Lofland G, Minn I, Yan Y, Jiang Z, Shin MJ, Merino VF, Zheng L, Brayton C, Pomper MG, Banerjee SR, Eur J Nucl Med Mol Imaging 2022 Nov 49 13 4369-4381

A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents.

Chen Y, Minn I, Rowe SP, Lisok A, Chatterjee S, Brummet M, Banerjee SR, Mease RC, Pomper MG, Biomolecules 2022 Mar 12 3

A Unique Core-Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects.

Cheng B, Ahn HH, Nam H, Jiang Z, Gao FJ, Minn I, Pomper MG, Pharmaceutics 2022 Feb 14 2

An Improved ²¹¹At-Labeled Agent for PSMA-Targeted α-Therapy.

Mease RC, Kang CM, Kumar V, Banerjee SR, Minn I, Brummet M, Gabrielson KL, Feng Y, Park A, Kiess AP, Sgouros G, Vaidyanathan G, Zalutsky MR, Pomper MG, J Nucl Med 2022 Feb 63 2 259-267

First-in-human neuroimaging of soluble epoxide hydrolase using [¹⁸F]FNDP PET.

Coughlin JM, Slania S, Du Y, Shinehouse LK, Brosnan MK, Azad BB, Holt DP, Fan H, Lesniak WG, Minn I, Rowe SP, Dannals RF, Horti AG, Pomper MG, Eur J Nucl Med Mol Imaging 2021 Sep 48 10 3122-3128

Targeted delivery of cytotoxic proteins to prostate cancer via conjugation to small molecule urea-based PSMA inhibitors.

Rogers OC, Rosen DM, Antony L, Harper HM, Das D, Yang X, Minn I, Mease RC, Pomper MG, Denmeade SR, Sci Rep 2021 Jul 11 1 14925

• Editors Choice Award
  The Journal of Nuclear Medicine, (2022)
• US President Service Award
  (2022)
• US President Service Award
  (2021)
• US President Service Award
  (2020)
• Editors Choice Award
  The Journal of Nuclear Medicine, (2017)

• American Association for Cancer Research (2011)
• American Society for Clinical Oncology (2023)
• American Society for Gene and Cell Therapy (2018)
• Society for Immunotherapy of Cancer (2018)
• Society for Nuclear Medicine and Molecular Imaging (2011)
• World Molecular Imaging Society (2011)